We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLBY icon
2826
Playboy Inc
PLBY
$141M
$129K ﹤0.01%
65,218
+12,416
+24% +$30.9K
LCUT icon
2827
Lifetime Brands
LCUT
$211M
$127K ﹤0.01%
21,576
+111
+0.5% +$791
SPIR icon
2828
Spire Global
SPIR
$555M
$127K ﹤0.01%
23,731
-211
-0.9% -$1.69K
WEAV icon
2829
Weave Communications
WEAV
$423M
$127K ﹤0.01%
25,529
+2,770
+12% +$13.9K
CMLS
2830
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$127K ﹤0.01%
34,444
+251
+0.7% +$1.41K
DBD
2831
DELISTED
Diebold Nixdorf Incorporated
DBD
$124K ﹤0.01%
103,114
+3,535
+4% +$7.86K
ML
2832
DELISTED
MoneyLion Inc.
ML
$122K ﹤0.01%
7,167
+195
+3% +$4.05K
FRBK
2833
DELISTED
Republic First Bancorp Inc
FRBK
$120K ﹤0.01%
87,888
+6,673
+8% +$13.1K
LTCH
2834
DELISTED
Latch, Inc. Common Stock
LTCH
$118K ﹤0.01%
155,169
+8,018
+5% +$6.58K
JNCE
2835
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$117K ﹤0.01%
63,356
+290
+0.5% +$359
ANTX icon
2836
AN2 Therapeutics
ANTX
$214M
$116K ﹤0.01%
11,710
+1,628
+16% +$18.1K
EYPT icon
2837
EyePoint Inc
EYPT
$1.2B
$115K ﹤0.01%
39,216
+1,481
+4% +$5.29K
NU icon
2838
Nu Holdings
NU
$66.9B
$115K ﹤0.01%
+24,097
New +$107K
VEL icon
2839
Velocity Financial
VEL
$729M
$115K ﹤0.01%
12,785
+94
+0.7% +$898
AMTX icon
2840
Aemetis
AMTX
$124M
$114K ﹤0.01%
49,157
-86
-0.2% -$320
VCSA
2841
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$113K ﹤0.01%
5,853
-861
-13% -$24.1K
HYFM icon
2842
Hydrofarm Holdings
HYFM
$7.62M
$111K ﹤0.01%
6,443
+4
+0.1% +$71
VERU icon
2843
Veru
VERU
$37.4M
$111K ﹤0.01%
9,574
+348
+4% +$14.1K
PFSW
2844
DELISTED
PFSweb, Inc.
PFSW
$109K ﹤0.01%
25,596
+385
+2% +$2.38K
GOSS icon
2845
Gossamer Bio
GOSS
$87M
$108K ﹤0.01%
85,361
+1,344
+2% +$2.57K
IPSC icon
2846
Century Therapeutics
IPSC
$361M
$108K ﹤0.01%
31,102
+363
+1% +$1.59K
TGAN
2847
DELISTED
Transphorm, Inc. Common Stock
TGAN
$108K ﹤0.01%
27,010
+915
+4% +$4.03K
GRSD
2848
Grandstand Limited Ordinary Shares
GRSD
$67M
$107K ﹤0.01%
10,845
+558
+5% +$5.36K
NL icon
2849
NLI Holdings
NL
$317M
$107K ﹤0.01%
17,715
+73
+0.4% +$506
LLAP
2850
DELISTED
Terran Orbital Corporation
LLAP
$106K ﹤0.01%
57,475
+10,390
+22% +$20K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.